excalibur
Diamond Member
- Mar 19, 2015
- 24,630
- 48,953
- 2,290
People warned about this drug. The all laughed because they have abortion as their sacrament and don't care what the consequences may be.
thefederalist.com
Abortion advocates, their allies in the corporate media, and even the U.S. Food and Drug Administration insist the pill responsible for more than half of the nation’s abortions is “safe and effective.” A new, wide-ranging analysis of insurance claims regarding the abortion drug regimen, however, found that the rate of life-threatening complications due to mifepristone is at least 22 times higher than what the FDA and Danco Laboratories, manufacturer of mifepristone pill Mifeprex, suggest.
In the “largest known study of the abortion pill,” Ethics and Public Policy Center President Ryan Anderson and Director of Data Analysis Jamie Bryan Hall used purchased Medicaid, TRICARE, Medicare, Department of Veterans Affairs, and private medical insurance claim data to determine that 865,727 mifepristone abortion prescriptions for 692,873 women were handed out between 2017 and 2023.
Approximately 10.9 percent of those claims, or 94,605 chemical abortions, involved potentially life-threatening “serious adverse events” such as emergency room visits, hemorrhage, sepsis, infection, and/or follow-up surgeries for the women who had downed the abortion drug within the last 45 days.

That rate, which researchers adjusted to reflect “that some women suffer from adverse events in multiple categories,” is 22 times the FDA’s <0.5 percent estimation printed on the Mifeprex label. The researchers also suggest that the 45-day timeframe they used is “conservative, as some adverse events may present later (and studies relied on by the FDA used a timeframe as long as 72 days).”
“This study is the statistical equivalent of a category 5 hurricane hitting the prevailing
narrative of the abortion industry,” Anderson said in a statement to The Federalist. “It reveals, based on real-world data, the shocking number of women who suffer serious medical consequences because of the abortion pill.”
The FDA, the study notes, derived its mifepristone data from 10 clinical trials. In 2000, the agency used those trials to justify fast-tracking abortion pill approval despite ongoing concerns about dangerous and fatal complications.
The researchers not only warned that some of those trials are outdated and were conducted outside of the U.S., but they also emphasized the trials only included a fraction — approximately 30,966 hand-selected, “prescreened,” “generally healthy women” — of the mifepristone patients reflected in the insurance data.
...

Abortion Pill Complication Rate 22 Times Higher Than FDA Claims
'The FDA should further investigate the harm this drug causes to women. ... Women deserve better than the abortion pill,' researchers say.
